WASHINGTON, D.C. — The Federal Trade Commission has warned 25 healthcare plan marketers and sales lead generators against misleading consumers about insurance coverage, costs and benefits as open enrollment gets underway, expanding regulatory scrutiny of companies selling health-related products.
FTC staff sent the warning letters last week to businesses advertising Affordable Care Act Marketplace insurance and other healthcare products, including limited indemnity plans and medical discount programs. The agency plans to issue additional letters on a rolling basis.
The warnings address marketing practices that could lead consumers to purchase products offering less coverage than advertised or to misunderstand the financial obligations associated with enrollment.
Among the practices identified by the FTC are representations that limited-benefit products provide comprehensive medical insurance, inaccurate descriptions of covered services and exclusions, and misleading statements about premiums or other costs.
The agency also cautioned companies against advertising nonexistent enrollment incentives, including purported cash rewards, rebates and free offers.
“Americans experiencing rising healthcare costs should not also have to worry about whether a healthcare plan or program is what it claims to be,” Christopher Mufarrige, director of the FTC’s Bureau of Consumer Protection, stated.
The distinction between comprehensive health insurance and limited-benefit products is particularly significant during open enrollment, when consumers may be comparing plans with substantially different coverage provisions.
Limited indemnity plans generally provide specified payments for qualifying medical events rather than the broader coverage associated with major medical insurance. Medical discount programs offer reduced prices for certain services but are not themselves health insurance.
The FTC’s letters direct recipients to review their advertising and sales practices for compliance with federal consumer protection requirements.
The agency cited previous enforcement actions involving Top Healthcare Options Insurance Agency, Innovative Partners, Assurance IQ and MediaAlpha, Simple Health Plans, Consumer Health Benefits, Benefytt Technologies and Partners in Healthcare as examples of conduct that has drawn regulatory intervention.
Those cases form part of the FTC’s enforcement history involving healthcare marketing and lead generation, where advertising practices can affect consumers before they speak directly with an insurer or plan representative.
The latest letters do not allege wrongdoing by any of the 25 recipients and do not constitute findings that the companies violated federal law.
Instead, the FTC is notifying businesses of potentially unlawful practices while continuing to monitor healthcare advertising during the enrollment period.
The agency indicated that companies engaging in deceptive or unfair marketing could face enforcement action under laws administered by the commission.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.